Biosynthesis of paclitaxel using synthetic biology

Yuru Tong,Yunfeng F Luo,Wei Gao
DOI: https://doi.org/10.1007/s11101-021-09766-0
2021-07-25
Phytochemistry Reviews
Abstract:Paclitaxel is a tricyclic diterpenoid first isolated from the bark of Taxus brevifolia. It is notably one of the most effective natural anticancer drugs discovered so far, and has been widely used in the treatment of breast, ovarian, lung cancer, as well as other diseases. However, the content of paclitaxel in the bark of yew trees is extremely low, thus alternative sources need to be developed urgently to meet the clinical demands. Using methods of synthetic biology to realize the heterologous expression of paclitaxel-related genes in microbial hosts could be a good choice. This paper reviews the advances in the researches on the biosynthesis of paclitaxel to provide new research strategies and insights.
plant sciences
What problem does this paper attempt to address?